October 2014

What Kind of Information Do Patients with Multiple Sclerosis Want?

February 10, 2015

Articles

Patients with multiple sclerosis (MS) often seek information from the Internet. Researchers in Italy interviewed 3 focus groups of patients with MS and 3 focus groups of family members of patients with MS to determine how physicians might improve access to the right type of information.

Evaluating the Evidence: Direct Comparative Trials in Multiple Sclerosis

February 10, 2015

Articles

Although 10 disease-modifying agents are available for patients with relapsing-remitting multiple sclerosis (RRMS), and more than 20 years have elapsed since the approval in the United States of the first traditional injectable agents for RRMS, until 2012 only 6 large head-to-head trials had evaluated these treatments directly.

Teva's Copaxone Now Available in a 3-Times-Weekly Regimen

February 09, 2015

Articles

Last year, Copaxone received US Food and Drug Administration (FDA) approval for a new 40-mg/mL subcutaneous injection used 3 times weekly, allowing for less frequent administration of the medication than the original 20-mg/mL daily subcutaneous injection.